HomeHealthCancer patients suffer as 40 drugs' approvals remain pending

Cancer patients suffer as 40 drugs’ approvals remain pending

Published on

spot_img


Cancer treatment drug in Provo, Utah, US, April 8, 2025. — ReutersPembrolizumab among 40 medicines awaiting approval. Patients increasingly rely on costly informal imports. Minister says government pursuing final approvals.

ISLAMABAD: A young woman battling…

Latest articles

More like this